Greenbrae, CA, United States of America

Peter Chang


 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Peter Chang

Introduction

Peter Chang is a notable inventor based in Greenbrae, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. With a total of five patents to his name, Chang's work is recognized for its potential impact on medical therapies.

Latest Patents

Among his latest patents are the "Anti-Ly6E antibodies and methods of use," which provide innovative solutions for targeting specific cancer cells. Another significant patent is the "Anti-Ly6E antibodies and immunoconjugates and methods of use," which outlines methods for treating cancer using these antibodies. These inventions highlight Chang's commitment to advancing cancer treatment through scientific innovation.

Career Highlights

Peter Chang is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on developing medicines for serious medical conditions. His work at Genentech has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Some of his notable coworkers include Chie Sakanaka and Jyoti Asundi, who share a commitment to advancing research and development in the field of biotechnology. Their collaborative efforts contribute to the innovative environment at Genentech.

Conclusion

In summary, Peter Chang is a distinguished inventor whose work in developing anti-Ly6E antibodies has the potential to transform cancer treatment. His contributions to biotechnology reflect a dedication to improving patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…